-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On Helus Pharma with Buy Rating, Announces Price Target of $8

Benzinga·04/13/2026 14:27:14
Listen to the news
TD Cowen analyst Ritu Baral initiates coverage on Helus Pharma (NASDAQ:HELP) with a Buy rating and announces Price Target of $8.